Drug
Fefinject
Fefinject: highest development phase Post-Market, developed by Vifor Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Vifor Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| FEFINJECT NCT04616092 | Post-Market | Cerebral Aneurysm Unruptured |
Latest
No recent events.
Follow Fefinject on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.